Introduction
iCAN is a groundbreaking Finnish Research Flagship dedicated to solving the cancer challenge through cutting-edge discovery and innovation. The flagship is at the interface of precision cancer medicine and digital health, with the aim of advancing research and providing innovative solutions to tackle cancer.
iCAN News
iCAN science seminar series, Autumn 2023
The iCAN science seminar series continues in the Autumn 2023. The program will be constantly updated, so do visit this…
Call for abstracts open for the 1st Helsinki Organ-on-a-chip meeting “From organoids to organisms” on Dec 11 2023
iCAN is proud to partner the first ever Helsinki Organ-on-a-chip meeting in December. The confirmed speakers include Prof. Peter Loskill…
Throwback to iCAN Scientific Retreat on 18.9.2023
On Monday 18.9.2023 the iCAN community gathered in the Conference Center Paasitorni, with additional participants online. During the day the…
iCAN in Numbers
iCAN Study Participants
Company collaborations
iCAN Publications
Invention
Disclosures
Patents
External Funding